mirabegron
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
28 FDA-registered drug labelers
Alivus Life Sciences Limited
ALMON HEALTHCARE PRIVATE LIMITED
Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.)
Astellas Ireland Co., Limited
Astellas Pharma US, Inc.
Aurobindo Pharma Limited
AX Pharmaceutical Corp
Biocon limited
Bryant Ranch Prepack
Calyx Chemicals & Pharmaceuticals Limited
Cardinal Health 107, LLC
Cohance Lifesciences Limited
Dr.Reddy's Laboratories Limited
Hetero Drugs Limited
Jiangxi Synergy Pharmaceutical Co., Ltd.
Jubilant Biosys limited
Lupin Pharmaceuticals, Inc.
Metrochem API Private Limited
MSN Laboratories Private Limited
Neuland Laboratories Limited
Piramal Pharma Limited
Qilu Pharmaceutical Co., Ltd.
RAKSHIT DRUGS PRIVATE LIMITED
REMEDYREPACK INC.
Sumitomo Chemical Company, Limited
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
Zydus Lifesciences Limited
Zydus Pharmaceuticals (USA) Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 3 drug and cosmetic product listings (FDA).
- •Myrbetriq
- •Mirabgeorn
- •Mirabegron
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS223673-61-8
PubChem CID9865528
DTXSIDDTXSID101021648
FormulaC21H24N4O2S
Mol. Weight396.5 g/mol
SMILESC1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
Data Sources
98655282026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/mirabegron/cids/JSON
Archive: data/sources/pubchem_name/mirabegron.json
CAS 223673-61-82026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json